Catalent
Catalent Braces for Potential Revenue Setback Following Sarepta’s Gene Therapy Trial Disappointment
Anika Sharma
Catalent, having overcome the challenges posed by the pandemic, now faces another potential setback in the form of what analysts ...
Catalent hires former Lonza bioscience chief to lead its biologics unit amid CEO departure
Anika Sharma
In a swift succession of leadership changes at Swiss contract development and manufacturing organization (CDMO) Lonza, David McErlane, the former ...
